Early and sustained benefits of budesonide and formoterol in a single inhaler vs fluticasone in moderate asthma

E. D. Bateman, T. A. Bantje, M. Joao Gomes, M. Toumbis, R. Huber, A. Eliraz (Cape Town, South Africa; Breda, The Netherlands; Lisbon, Portugal; Athens, Greece; Munich, Germany; Rehovot, Israel)

Source: Annual Congress 2001 - Asthma treatment
Session: Asthma treatment
Session type: Poster Discussion
Number: 1066
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. D. Bateman, T. A. Bantje, M. Joao Gomes, M. Toumbis, R. Huber, A. Eliraz (Cape Town, South Africa; Breda, The Netherlands; Lisbon, Portugal; Athens, Greece; Munich, Germany; Rehovot, Israel). Early and sustained benefits of budesonide and formoterol in a single inhaler vs fluticasone in moderate asthma. Eur Respir J 2001; 16: Suppl. 31, 1066

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cost-effectiveness of budesonide and formoterol in a single inhaler compared to fluticasone in the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 157s
Year: 2001

Budesonide and formoterol in a single inhaler quickly gains asthma control compared with fluticasone propionate in mild asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Budesonide/formoterol in a single inhaler once or twice daily provides better asthma control than inhaled fluticasone or budesonide alone in patients with moderate persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 387s
Year: 2002

Budesonide and formoterol in a single inhaler is more effective than a higher dose of inhaled corticosteroid in mild-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001

Efficacy and safety of the new beclomethasone dipropionate/formoterol combination vs. fluticasone propionate/salmeterol pMDIs in moderate to severe persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 205s
Year: 2006

Adjustable maintenance treatment of asthma with budesonide and formoterol in a single inhaler
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002

Comparison of a combination of tiotropium and formoterol to salmeterol and fluticasone in moderate COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 14s
Year: 2005

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone
Source: Eur Respir J 2001; 18: 262-268
Year: 2001



Once-daily, high-dose inhaled fluticasone propionate and salmeterol in patients having moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Montelukast and budesonide vs double dose budesonide in moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

Budesonide and formoterol in a single inhaler controls exacerbations more effectively than a higher dose of inhaled corticosteroids alone, in mild-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 43s
Year: 2001

Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

Initial maintenance therapy with fluticasone propionate/ salmeterol combination product provides superior asthma control versus montelukast or fluticasone propionate alone
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
Source: Eur Respir J 2014; 43: 763-772
Year: 2014



Treatment effectiveness and exacerbations during one year with seretide compared to fluticasone propionate and salmeterol in mild-to-moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 176s
Year: 2001

Airway and systemic effects of hydrofluoroalkane formulations of high dose ciclesonide and fluticasone propionate in moderate persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 583s
Year: 2004

Same minimal effective dose of budesonide Turbuhaler® and fluticasone Diskus®/Accuhaler® in adult asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 158s
Year: 2001

Improved asthma control with budesonide/formoterol via a single inhaler, compared with budesonide alone, in moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Efficacy of long-term formoterol therapy vs as-needed salbutamol use in patients with moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 426s
Year: 2001

Budesonide and formoterol in a single inhaler is safe and effective in the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001